Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema.

PURPOSE To describe the changes in retinal vascular caliber in response to a single injection of intravitreal triamcinolone (IVTA) in patients with refractory diabetic macular edema. METHODS Prospective data from a randomized clinical trial were used. The effects of IVTA versus sham injections in patients with refractory diabetic macular edema were evaluated in a randomized clinical trial involving 69 eyes of 43 patients. Of these, 28 eyes (15 IVTA and 13 sham) of 21 patients had gradable retinal photographs at the baseline and 3-month follow-up visit for analysis in the present study. Retinal vascular caliber was measured from digital fundus photographs and summarized as central retinal artery (CRAE) and vein (CRVE) equivalents in all eyes at baseline and at the 3-month follow-up visit. RESULTS Over the 3 months of the study, there was a significant reduction compared to baseline in retinal arteriolar (147.8 microm vs. 140.0 microm, P = 0.047) and venular (219.5 microm vs. 198 microm, P = 0.039) caliber in eyes treated with IVTA. There was no change in retinal arteriolar (139.9 microm vs. 139.2 microm, P = 0.878) or venular (220.3 microm vs. 217.6 microm, P = 0.534) caliber in those treated with sham injections. CONCLUSIONS IVTA has a significant narrowing effect on both retinal arteriolar and venular diameter in eyes with diabetic macular edema (ClinicalTrials.gov number, NCT00148330).

[1]  Cong Sun,et al.  Retinal vascular caliber, blood pressure, and cardiovascular risk factors in an Asian population: the Singapore Malay Eye Study. , 2008, Investigative ophthalmology & visual science.

[2]  Tien Yin Wong,et al.  Relationship of Retinal Vascular Caliber With Diabetes and Retinopathy , 2008, Diabetes Care.

[3]  M. Larsen,et al.  Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter. , 2007, Investigative ophthalmology & visual science.

[4]  M. Larsen,et al.  Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema. , 2006, Acta ophthalmologica Scandinavica.

[5]  Ronald Klein,et al.  Retinal vascular caliber in persons with type 2 diabetes: the Wisconsin Epidemiological Study of Diabetic Retinopathy: XX. , 2006, Ophthalmology.

[6]  J. Simpson,et al.  Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. , 2006, Ophthalmology.

[7]  R. Klein,et al.  Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA). , 2006, Investigative ophthalmology & visual science.

[8]  R. Klein,et al.  Diabetic retinopathy in a multi-ethnic cohort in the United States. , 2006, American journal of ophthalmology.

[9]  A. Hofman,et al.  Retinal vessel diameters and risk of impaired fasting glucose or diabetes: the Rotterdam study. , 2006, Diabetes.

[10]  E. Agrón,et al.  Serum inflammatory markers in diabetic retinopathy. , 2005, Investigative ophthalmology & visual science.

[11]  C. D. A. Stehouwer,et al.  Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study , 2005, Diabetologia.

[12]  A. E. Caballero,et al.  Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation. , 2005, Archives of medical research.

[13]  Hiroshi Tamura,et al.  Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. , 2005, Investigative ophthalmology & visual science.

[14]  J. Jonas,et al.  Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study , 2005, British Journal of Ophthalmology.

[15]  S. Bakri,et al.  Intravitreal triamcinolone injection for diabetic macular edema: a clinical and fluorescein angiographic case series. , 2004, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[16]  W. Chan,et al.  Intravitreal triamcinolone for diabetic macular oedema in Chinese patients: six‐month prospective longitudinal pilot study , 2004, Clinical & experimental ophthalmology.

[17]  J. Simpson,et al.  Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. , 2004, Ophthalmology.

[18]  Ulrich Schraermeyer,et al.  A central role for inflammation in the pathogenesis of diabetic retinopathy , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  A. Hofman,et al.  Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study. , 2004, Investigative ophthalmology & visual science.

[20]  R. Klein,et al.  Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. , 2004, Ophthalmology.

[21]  J. Edelman,et al.  Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown. , 2004, Experimental eye research.

[22]  A. Erginay,et al.  Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. , 2004 .

[23]  R. Klein,et al.  Retinal vascular abnormalities in persons with type 1 diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVIII. , 2003, Ophthalmology.

[24]  R. Klein,et al.  Revised formulas for summarizing retinal vessel diameters , 2003, Current eye research.

[25]  J. Jonas,et al.  Intravitreale Injektion von kristallinem Triamcinolon Acetonid als Therapie des diffusen diabetischen Makulaödems , 2002 .

[26]  J. Duker,et al.  Intravitreal triamcinolone for refractory diabetic macular edema. , 2002, Ophthalmology.

[27]  Bernd Kirchhof,et al.  Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. , 2002, The American journal of pathology.

[28]  J. Jonas,et al.  Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. , 2001, American journal of ophthalmology.

[29]  R. Klein,et al.  Are retinal arteriolar abnormalities related to atherosclerosis?: The Atherosclerosis Risk in Communities Study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[30]  A. Ahluwalia,et al.  The Microcirculation and Inflammation: Site of Action for Glucocorticoids , 2000, Microcirculation.

[31]  R. Klein,et al.  Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. , 1999, Ophthalmology.

[32]  C. A. Wilson,et al.  Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. , 1992, Archives of ophthalmology.

[33]  B. Petrig,et al.  Diabetic Glycemic Control and Retinal Blood Flow , 1990, Diabetes.

[34]  B L Petrig,et al.  Blood velocity and volumetric flow rate in human retinal vessels. , 1985, Investigative ophthalmology & visual science.

[35]  F L Ferris,et al.  Macular edema. A complication of diabetic retinopathy. , 1984, Survey of ophthalmology.

[36]  E. Kohner.  4 Diabetic retinopathy , 1977 .

[37]  F Skovborg,et al.  Diameters of the Retinal Vessels in Diabetic and Normal Subjects , 1969, Diabetes.

[38]  Ronald Klein,et al.  Are inflammatory factors related to retinal vessel caliber? The Beaver Dam Eye Study. , 2006, Archives of ophthalmology.

[39]  C. Evereklioglu,et al.  Intravitreal Triamcinolone Acetonide Injection as Primary Treatment for Diabetic Macular Edema , 2004, European journal of ophthalmology.

[40]  W. Vilser,et al.  Autoregulative behavior of retinal arteries and veins during changes of perfusion pressure: a clinical study , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[41]  J. Jonas,et al.  Intravitreal injection of triamcinolone for diffuse diabetic macular edema. , 2003, Archives of ophthalmology.

[42]  J. Jonas,et al.  [Intravitreal injection of crystalline triamcinolone acetonide in the treatment of diffuse diabetic macular oedema]. , 2002, Klinische Monatsblatter fur Augenheilkunde.

[43]  J. Mora,et al.  Intravitreal triamcinolone for refractory diabetic macular edema , 2002 .

[44]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.